chr10-49648606-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_020549.5(CHAT):c.1381G>A(p.Val461Met) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.994 in 1,609,818 control chromosomes in the GnomAD database, including 795,386 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_020549.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHAT | NM_020549.5 | c.1381G>A | p.Val461Met | missense_variant, splice_region_variant | 9/15 | ENST00000337653.7 | NP_065574.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHAT | ENST00000337653.7 | c.1381G>A | p.Val461Met | missense_variant, splice_region_variant | 9/15 | 1 | NM_020549.5 | ENSP00000337103.2 |
Frequencies
GnomAD3 genomes AF: 0.968 AC: 147239AN: 152126Hom.: 71478 Cov.: 32
GnomAD3 exomes AF: 0.991 AC: 246545AN: 248716Hom.: 122287 AF XY: 0.994 AC XY: 133709AN XY: 134570
GnomAD4 exome AF: 0.996 AC: 1452385AN: 1457574Hom.: 723860 Cov.: 32 AF XY: 0.997 AC XY: 722972AN XY: 725220
GnomAD4 genome AF: 0.968 AC: 147345AN: 152244Hom.: 71526 Cov.: 32 AF XY: 0.969 AC XY: 72135AN XY: 74430
ClinVar
Submissions by phenotype
Familial infantile myasthenia Benign:3
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 22, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 21, 2014 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at